Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients

Cytogenetics and Cell Genetics

Volumn 87, Issue 1-2, 1999, Pages 41-46

  Migliore, Lucia ^a   Botto, N ^a   Scarpato, R ^a   Petrozzi, L ^b   Cipriani, G ^c   Bonuccelli, U ^a,b  

^a Dipto Sci dell'Uomo dell'Ambiente   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c OSPEDALE DEGLI INFERMI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN B;

ADULT; AGED; ALZHEIMER DISEASE; ANEUPLOIDY; ARTICLE; CHROMOSOME 13; CHROMOSOME 21; CHROMOSOME LOSS; CHROMOSOME SEGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; COSMID; CYTOGENETICS; DNA PROBE; DOWN SYNDROME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; MALE; MOLECULAR GENETICS; MOSAICISM; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0033399922     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015389     Document Type: Article

References (36)

1. Bales KK, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM: Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet 17:263-264 (1997).
2. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RCP, Perry R, Watson BJ, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE: Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nature Genet 19:357-360 (1998).
3. Blass JP: Pathophysiology of the Alzheimer's syndrome. Neurology 43(Suppl 4):S25-38 (1993).
4. Cherry LM, Funk J, Lesser JM, Lesam M: Gender differences and the interpretation of genetic instability in Alzheimer's disease. Mutat Res 275:57-67 (1992).
5. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G., Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens. J, Kim S, Schenk D, Fraser P. St. George Hyslop P, Selkoe DJ: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med 3:67-72 (1997).
6. Cruts M, Hendriks L, Van Broeckhoven C: The presenilin genes: a new gene family involved in Alzheimer disease pathology. Hum molec Genet 5:1449-1455 (1996).
7. Fenech M: The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 285:35-44 (1993).
8. Geller LN, Potter H: Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol Dis 6:167-179 (1999).
9. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc natl Acad Sci, USA 83:4913-4917 (1986).
10. Holtzman DM: Alzheimer disease and Down syndrome. Cytogenet Cell Genet 77(Suppl 1):17 (1997).
11. Jarvik LF, Yen F-S, Goldstein F: Chromosomes and mental status. Arch gen Psychiatr 30:186-190 (1974).
12. Kay DWK: Genetics, Alzheimer's disease and senile dementia. Br J Psychiatr 154:311-320 (1989).
13. Keller JN, Guo Q, Holtsberg FW, Bruce-Keller AJ, Mattson MP: Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 18:4439-4450 (1998).
14. Li J, Xu M, Zhou H, Ma J, Potter H: Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90:917-927 (1997).
15. Marshall RR, Murphy M, Kirkland DJ, Bentley BS: Fluorescence in situ hybridization with chromosome specific centromeric probes: a sensitive method to detect aneuploidy. Mutat Res 372:221-233 (1996).
16. Matsuyama SS, Jarvik LF: Hypothesis: microtubules, a key to Alzheimer disease, Proc natl Acad Sci, USA 86:8152-8156 (1989).
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944 (1984).
18. Migliore L, Testa A, Scarpato R, Pavese N, Petrozzi L, Bonuccelli U: Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet 101:299-305 (1997).
19. Moorhead PS, Heyman A: Chromosome studies of patients with Alzheimer disease. Am J med Genet 14:545-556 (1983).
20. Nagy ZS, Esiri MM, Smith AD: The cell pathophysiology of Alzheimer's disease. Neuroscience 87:731-739 (1998).
21. Percy ME, Markovic VD, Dalton AJ, McLachlan DRC, Berg JM, Rusk ACM, Somerville MJ, Chodakowski B, Andrews DF: Age-associated chromosome 21 loss in Down syndrome: possible relevance to mosaicism and Alzheimer disease. Am J med Genet 45:584-588 (1993).
22. Potter H: Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders. Am J hum Genet 48:1192-1200 (1991).
23. Potter H, Geller LN: Alzheimer's disease, Down's syndrome, and chromosome segregation. Lancet 348:66 (1996).
24. Prasher VP, Farrer MJ, Kessling AM, Fisher EMC, West RJ, Barber PC, Butler AC: Molecular mapping of Alzheimer-type dementia in Down's syndrome. Annls Neurol 43:380-383 (1998).
25. Preuss U, Mandelkow EM: Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease. Eur J Cell Biol 76:176-184 (1998).
26. Reisberg B, Ferris SN, de Leon MJ, Crook KT: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatr 139:1136-1139 (1982).
27. Schellenberg GD: Inheritance and Alzheimer's disease, in Alzheimer's Disease: Syllabus of the 1995 Meeting of the American Academy of Neurology 143:31-41 (1995).
28. Schupf N, Kapell D, Lee JH, Ottman R, Mayeux R: Increased risk of Alzhcimer's disease in mothers of adults with Down's syndrome. Lancet 344:353-356 (1994).
29. Smith MA, Siedlak SL, Richey PL, Mulvihill P, Ghiso J, Frangione B, Tagliavini F, Giaccone G, Bugiani O, Praprotnik D, Kalaria RN, Perry G: Tau protein directly interacts with the amyloid β-protein precursor: implications for Alzheimer's disease. Nature Med 1:365-369 (1995).
30. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer disease. Proc natl Acad Sci, USA 92:4725-4727 (1995).
31. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong L-M, Jakes R, Alberts MJ, Gilbert JR, Han SH, Hulette C, Einstein G, Schemeehel DE, Pericak-Vance MA, Roses AD: Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Expl Neurol 125:163-171 (1994).
32. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K-H, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA. Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B: Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc natl Acad Sci, USA 94:13287-13292 (1997).
33. Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F., Scartezzini P, Bertolini S, Mann DMA, Tabaton M, Gambetti P: Presence of soluble amyloid plaque formation in Down's syndrome. Nature Med 2:93-95 (1996).
34. Tyrrel J, Cosgrave M, Hawi Z, McPherson J, O'Brien C, McCalvert J, McLaughlin M, Lawlor B, Gill M: A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Biol Psychiatr 43:397-400 (1998).
35. Van Broeckhoven C: Presenilins and Alzheimer disease. Nature Genet 11:230-232 (1995).
36. White BJ, Crandall C, Goldsmit J, Morrow CH, Ailing DW, Carleton Gajdusek DC, Tjio J-H: Cytogenetic studies of familial and sporadic Alzheimer disease. Am J med Genet 10:77-89 (1981).